Evidence map›Paper›PMID 41532375›Full record

ArticleThe Libyan journal of medicine2026

Unregulated use of

Inas Alhudiri, Fawzi Ebrahim, Adam Elzagheid

Abstract readLetter
In one paragraph

Article in The Libyan journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Inas AlhudiriGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0002-3371-0215
Fawzi EbrahimTissue and Cell Culture Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0002-4420-8423
Adam ElzagheidGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0002-7086-5937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A concerning trend has recently emerged in Libya where cancer patients are seeking unproven herbal remedies derived from local Artemisia species driven by circulating claims on social media. These unregulated traditional medicines can interact with standard cancer treatments such as chemotherapy and radiation therapy. Scientific evidence suggests that

Indexed as

ArtemisiaNeoplasmsPhytotherapyPublic HealthHerb-Drug InteractionsHumansLibyaArtemisiaherb-drug interactionsLibyaoncology carepatient safety

Identifiers

PMID41532375
PMCPMC12805842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.